Category: Oncology/Hematology
Global Oncology/Hematology
-
Oncology Based In-Vivo CRO Market by Services (Biomarker Development, Clinical Trial Management, Pharmacokinetics Studies), Indication (Hematological Malignancies, Rare Cancer, Solid Tumor), End-User - Global Forecast 2024-2030
... at USD 1.27 billion in 2023 and expected to reach USD 1.41 billion in 2024, at a CAGR 11.34% to reach USD 2.70 billion by 2030. Global Oncology Based In-Vivo CRO Market FPNV Positioning Matrix ... Read More
-
Prostate Cancer Therapeutics Market by Drug Class (Chemotherapy, Hormonal Therapy, Immunotherapy), Distribution Channel (Drug Stores & Retail Pharmacies, Hospitals Pharmacies, Online Pharmacies) - Global Forecast 2024-2030
... USD 10.00 billion in 2023 and expected to reach USD 10.62 billion in 2024, at a CAGR 6.32% to reach USD 15.36 billion by 2030. Global Prostate Cancer Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Hematological Malignancies Market by Types (Leukemia, Lymphoma, Multiple Myeloma), Treatment (Bone Marrow Transplantation, Chemotherapy, Chimeric Antigen Receptor (Car) T Cell Therapy), Diagnosis, End-Users - Global Forecast 2024-2030
... USD 15.33 billion in 2023 and expected to reach USD 16.84 billion in 2024, at a CAGR 9.92% to reach USD 29.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Acute Lymphoblastic Leukemia Treatment Market (ALL) by Types of Cell (B-cell ALL, Philadelphia chromosome: Positive (Ph+) and negative (Ph-), T-cell ALL), Therapy (Chemotherapy, Radiation Therapy, Stem Cell Transplantation), End-User - Global Forecast 202
... Lymphoblastic Leukemia Treatment Market size was estimated at USD 3.22 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 6.45% to reach USD 4.99 billion by 2030. FPNV Positioning ... Read More
-
Antibody Drug Conjugates Contract Manufacturing Market by Linker (Cleavable, Non-cleavable), Condition (Breast Cancer, Lymphoma, Myeloma), End Use - Global Forecast 2024-2030
... in 2023 and expected to reach USD 13.06 billion in 2024, at a CAGR 11.82% to reach USD 25.99 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antibody ... Read More
-
In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.19 billion in 2024, at a CAGR 7.01% to reach USD 4.85 billion by 2030. Global In Silico Clinical Trials Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Combination Antibody Therapy Market by Type (Antibody-Drug Conjugates, Bispecific Antibodies, Chemotherapy-Monoclonal Antibodies), Indication (Cancer, HIV), Route of Administration, Distribution Channel, End-Use - Global Forecast 2024-2030
... 209.37 billion in 2023 and expected to reach USD 231.55 billion in 2024, at a CAGR 9.30% to reach USD 390.18 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Bone Marrow Transplantation Market by Type (Allogeneic Transplant, Autologous Transplant), Treatment Type (Aplastic Anemia, Leukemia, Lymphoma), End-User - Global Forecast 2024-2030
... and expected to reach USD 17.62 billion in 2024, at a CAGR 8.74% to reach USD 29.26 billion by 2030. Global Bone Marrow Transplantation Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Skin Cancer Dermatology Market by Test (Dermatoscopy, Diagnostic Imaging, Lymph Node Biopsy), Age Group (0-19, 20-39, 40-59), Facility Type - Global Forecast 2024-2030
... in 2023 and expected to reach USD 8.42 billion in 2024, at a CAGR 7.40% to reach USD 12.83 billion by 2030. Global Skin Cancer Dermatology Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Global Forecast 2024-2030
... at USD 7.34 billion in 2023 and expected to reach USD 7.67 billion in 2024, at a CAGR 9.10% to reach USD 13.51 billion by 2030. Global Oncology Precision Medicine Market FPNV Positioning Matrix The ... Read More
-
Transcatheter Devices Market by Product (Transcatheter Embolization & Occlusion Devices, Transcatheter Repair Devices, Transcatheter Replacement Devices), Application (Cardiovascular, Neurology, Oncology) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 15.97 billion in 2024, at a CAGR 13.70% to reach USD 34.56 billion by 2030. Global Transcatheter Devices Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 302.68 billion in 2024, at a CAGR 5.39% to reach USD 415.18 billion by 2030. Global Biologics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Global Forecast 2024-2030
... Based Therapies Market size was estimated at USD 7.17 billion in 2023 and expected to reach USD 8.22 billion in 2024, at a CAGR 14.78% to reach USD 18.83 billion by 2030. FPNV Positioning Matrix ... Read More
-
Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Indication (B-Cell Malignancies, Liver Cancer, Prostate Cancer), Technology Type, End-Use - Global Forecast 2024-2030
... at USD 11.23 billion in 2023 and expected to reach USD 14.02 billion in 2024, at a CAGR 25.34% to reach USD 54.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Cancer Biological Therapy Market by Product (Cancer Growth Blockers, Monoclonal Antibodies, Vaccines), Route of Administration (Intramuscular, Intravenous, Subcutaneous), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 72.42 billion in 2024, at a CAGR 11.60% to reach USD 140.04 billion by 2030. Global Cancer Biological Therapy Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Cancer Immunotherapy Drugs Market by Type (Cancer Vaccines, Checkpoint Inhibitors, Immunomodulators), Indication (Breast Cancer, Colorectal Cancer, Head & Neck Cancer), End-user - Global Forecast 2024-2030
... 215.29 billion in 2023 and expected to reach USD 243.31 billion in 2024, at a CAGR 13.10% to reach USD 509.93 billion by 2030. Global Cancer Immunotherapy Drugs Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Women’s Health Diagnostics Market by Type (Point-of-Care, Self Check), Application (Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing), End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 46.82 billion in 2024, at a CAGR 9.25% to reach USD 80.59 billion by 2030. Global Women’s Health Diagnostics Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type (Breast, Colorectal, Head and Neck), Drug Type (Immunomodulators, Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines), Service Type - Global Forecast 2024-2030
... Discovery Outsourcing Market size was estimated at USD 1.60 billion in 2023 and expected to reach USD 1.84 billion in 2024, at a CAGR 15.59% to reach USD 4.41 billion by 2030. Global Cancer Immunotherapy ... Read More
-
Flow Cytometry in Oncology & Immunology Market by Type (Immunology, Oncology), Technology (Bead-based Flow Cytometry, Cell-based Flow Cytometry), Product & Service, End User - Global Forecast 2024-2030
... size was estimated at USD 1.10 billion in 2023 and expected to reach USD 1.18 billion in 2024, at a CAGR 9.33% to reach USD 2.06 billion by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Erythropoietin Stimulating Agents Market by Type (Darbepoetin Alfa, Epoetin Alfa, Epoetin Beta), Application (Anemia, Antiretroviral Treatment, Cancer Chemotherapy) - Global Forecast 2024-2030
... 2023 and expected to reach USD 10.32 billion in 2024, at a CAGR 5.64% to reach USD 14.45 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Erythropoietin Stimulating ... Read More
-
Solid Tumor Cancer Treatment Global Market Report 2024
... Hospitals; Research Institutes; HomecareCovering: AstraZeneca plc; Amgen Inc.; B. Braun Melsungen AG; Bristol Myers Squibb & Company; Eli Lilly & Company Solid Tumor Cancer Treatment Global Market Report 2024 from The Business Research Company provides ... Read More
-
Cancer Profiling Global Market Report 2024
... Colorectal Cancer; Prostate Cancer; Melanoma Cancer4) By Application: Research Applications; Clinical Applications; Screening; Diagnostics; PrognosticsCovering: Illumina Inc.; Qiagen NV; NeoGenomics Inc.; Sysmex Corporation; HTG Molecular Diagnostics Inc. Cancer Profiling Global Market Report 2024 from The ... Read More
-
Radiation Dose Management Market by Offering (Product: Integrated, Standalone; Services), Modality (CT, Mammography, NM), Revenue Model (Pay-Per Procedure, Annual Purchase), Application (Oncology, Cardiology, Ortho), End User - Global Forecast to 2028
... management market is projected to reach USD 654 million by 2028 from USD 343 million in 2023, at a CAGR of 13.8% from 2023 to 2028. The growth of the market is driven by a ... Read More
-
Global Oncology Based Molecular Diagnostics Market Size Study & Forecast, by Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Others), by Product (Instruments, Reagents, Others), by Technology (PCR, In situ hybridization, INAAT, Chips and microarrays, Mass spectrometry, Sequencing, TMA, Others), and Regional Analysis, 2023-2030
... In situ hybridization, INAAT, Chips and microarrays, Mass spectrometry, Sequencing, TMA, Others), and Regional Analysis, 2023-2030 Global Oncology Based Molecular Diagnostics Market is valued at approximately USD 2.44 billion in 2022 and is anticipated to ... Read More
-
Global Colorectal Cancer Molecular Diagnostics Market Research Report 2024(Status and Outlook)
... 601.76 million by 2029, exhibiting a CAGR of 14.20% during the forecast period. This report provides a deep insight into the global Colorectal Cancer Molecular Diagnostics market covering all its essential aspects. This ranges from ... Read More
Research Assistance
